title: The interaction of calcium entry and calcium sensitization in the control of vascular tone and blood pressure of normotensive and hypertensive rats.
abstract: Increased systemic vascular resistance is responsible for blood pressure (BP) elevation in most forms of human or experimental hypertension. The enhanced contractility of structurally remodeled resistance arterioles is mediated by enhanced calcium entry (through L type voltage-dependent calcium channels - L-VDCC) and/or augmented calcium sensitization (mediated by RhoA/Rho kinase pathway). It is rather difficult to evaluate separately the role of these two pathways in BP control because BP response to the blockade of either pathway is always dependent on the concomitant activity of the complementary pathway. Moreover, vasoconstrictor systems enhance the activity of both pathways, while vasodilators attenuate them. The basal fasudil-sensitive calcium sensitization determined in rats deprived of endogenous renin-angiotensin system (RAS) and sympathetic nervous system (SNS) in which calcium entry was dose-dependently increased by L-VDCC opener BAY K8644, is smaller in spontaneously hypertensive rats (SHR) than in normotensive Wistar-Kyoto (WKY) rats. In contrast, if endogenous RAS and SNS were present in intact rats, fasudil caused a greater BP fall in SHR than WKY rats. Our in vivo experiments indicated that the endogenous pressor systems (RAS and SNS) augment calcium sensitization mediated by RhoA/Rho kinase pathway, whereas the endogenous vasodilator systems (such as nitric oxide) attenuate this pathway. However, the modulation of calcium entry and calcium sensitization by nitric oxide is strain-dependent because NO deficiency significantly augments low calcium entry in WKY and low calcium sensitization in SHR. Further in vivo and in vitro experiments should clarify the interrelationships between endogenous vasoactive systems and the contribution of calcium entry and/or calcium sensitization to BP maintenance in various forms of experimental hypertension.
authors.affiliation: Department of Experimental Hypertension, Institute of Physiology Academy of Sciences of the Czech Republic, Prague, Czech Republic. zicha@biomed.cas.cz.
authors.forename: J
authors.initials: J
authors.lastname: Zicha
authors.forename: M
authors.initials: M
authors.lastname: Behuliak
authors.forename: M
authors.initials: M
authors.lastname: Pintérová
authors.forename: M
authors.initials: M
authors.lastname: Bencze
authors.forename: J
authors.initials: J
authors.lastname: Kuneš
authors.forename: I
authors.initials: I
authors.lastname: Vaněčková
mesh_terms: D000818:Animals; D001794:Blood Pressure; D002118:Calcium / Q000378:metabolism*; D015220:Calcium Channels / Q000378:metabolism*; D020013:Calcium Signaling; D006973:Hypertension / Q000503:physiopathology*; D015640:Ion Channel Gating; D008955:Models, Cardiovascular; D051381:Rats; D011918:Rats, Inbred SHR; D012084:Renin-Angiotensin System; D014661:Vasoconstriction; D020742:rhoA GTP-Binding Protein / Q000378:metabolism
chemical_list: D015220:Calcium Channels; D020742:rhoA GTP-Binding Protein; D002118:Calcium